Tag: Monthly

Posted on

Work-Related Asthma Underdiagnosed, Under-Recognized – Monthly Prescribing Reference


HCPLive

Work-Related Asthma Underdiagnosed, Under-Recognized
Monthly Prescribing Reference
(HealthDay News) — Only 15 percent of working adults with asthma discuss with their doctor how their jobs might affect their breathing, even though nearly half have asthma that is possibly work-related, according to a study published in the February …
Why Patients Won't Talk to Their Docs About Work-Related AsthmaAllergic Living
Demographics, not location, explain high inner-city asthma ratesClinical Advisor
Can we talk? Patients may avoid topic of work-related asthma for fear of …Medical Xpress
Philly.com
all 11 news articles »

View full post on asthma – Google News

Posted on

New Inhalers for Asthma, COPD Launched – Monthly Prescribing Reference


Monthly Prescribing Reference

New Inhalers for Asthma, COPD Launched
Monthly Prescribing Reference
GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation powder). Arnuity Ellipta is an inhaled corticosteroid indicated for the maintenance treatment of asthma …
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
GSK expands its portfolio of medicines in the US for patients with asthma and …MarketWatch

all 6 news articles »

View full post on asthma – Google News

Posted on

Is SLIT-Tablet Tx Safe for Asthma Patients with Allergic Rhinitis? – Monthly Prescribing Reference

Is SLIT-Tablet Tx Safe for Asthma Patients with Allergic Rhinitis?
Monthly Prescribing Reference
All subjects had a confirmed diagnosis of grass-pollen-induced AR/C with or without controlled asthma and a history of medication use to treat symptoms of AR/C during the previous pollen season. A total of 3,314 adult patients and 881 pediatric …

View full post on asthma – Google News

Posted on

Does Umeclidinium Monotherapy Help Asthma Patients Without ICS? – Monthly Prescribing Reference

Does Umeclidinium Monotherapy Help Asthma Patients Without ICS?
Monthly Prescribing Reference
However, no studies have assessed a long-acting muscarinic antagonist in the absence of inhaled corticosteroids (ICS) for asthma patients. A new study in Respiratory Medicine reports on a double-blind, three-period crossover study of 350 asthma …

View full post on asthma – Google News

Posted on

Overweight Children More Likely to Report Worse Asthma Control – Monthly Prescribing Reference


Monthly Prescribing Reference

Overweight Children More Likely to Report Worse Asthma Control
Monthly Prescribing Reference
Children with early-onset asthma who are overweight or obese may mistake exertional dyspnea and esophageal reflux for loss of asthma control, causing them to use more rescue medication. In a study published in the Journal of Allergy and Clinical …
Overweight kids misinterpret asthma symptoms, potentially overuse medicationEurekAlert (press release)
Obese Asthmatics Overuse Rescue MedicationsPharmacy Times
Seven recent developments involving food allergyHealio

all 7 news articles »

View full post on asthma – Google News

Posted on

FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events – Monthly Prescribing Reference

FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events
Monthly Prescribing Reference
The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with …
Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of …EIN News (press release)

all 2 news articles »

View full post on asthma – Google News

Posted on

Positive Results for Reslizumab in Asthma Trials – Monthly Prescribing Reference

Positive Results for Reslizumab in Asthma Trials
Monthly Prescribing Reference
Teva announced positive results from its Phase 3 studies of reslizumab in patients with uncontrolled moderate to severe asthma with elevated eosinophils, treated with standard of care therapies. Reslizumab is an investigational humanized monoclonal …
Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 TrialsNASDAQ

all 7 news articles »

View full post on asthma – Google News

Posted on

Once-Daily Fluticasone Furoate May Be Effective for Persistent Asthma – Monthly Prescribing Reference

Once-Daily Fluticasone Furoate May Be Effective for Persistent Asthma
Monthly Prescribing Reference
A new study published in the journal Respiratory Research evaluates the use of a once-daily dosing regimen for the inhaled corticosteroid (ICS) fluticasone furoate vs. placebo in patients with asthma uncontrolled by non-inhaled corticosteroids …

View full post on asthma – Google News